Patents by Inventor Nicholas S. Bodor

Nicholas S. Bodor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240261262
    Abstract: Intra-oral formulations comprising soft anticholinergic alkyl esters are useful for treating excessive drooling conditions in subjects, such as humans, suffering from sialorrhea. Preferably, at least one soft anticholinergic ester is provided in an effective amount or concentration in an anhydrous intra-oral formulation that can inhibit excessive drooling resulting from a condition known as sialorrhea.
    Type: Application
    Filed: March 8, 2024
    Publication date: August 8, 2024
    Inventor: Nicholas S. BODOR
  • Patent number: 11951093
    Abstract: Intra-oral formulations comprising soft anticholinergic alkyl esters are useful for treating excessive drooling conditions in subjects, such as humans, suffering from sialorrhea. Preferably, at least one soft anticholinergic ester is provided in an effective amount or concentration in an anhydrous intra-oral formulation that can inhibit excessive drooling resulting from a condition known as sialorrhea.
    Type: Grant
    Filed: June 23, 2022
    Date of Patent: April 9, 2024
    Assignee: BODOR LABORATORIES, INC.
    Inventor: Nicholas S. Bodor
  • Patent number: 11534422
    Abstract: Intra-oral formulations comprising soft anticholinergic alkyl esters are useful for treating excessive drooling conditions in subjects, such as humans, suffering from sialorrhea. Preferably, at least one soft anticholinergic ester is provided in an effective amount or concentration in an anhydrous intra-oral formulation that can inhibit excessive drooling resulting from a condition known as sialorrhea.
    Type: Grant
    Filed: September 6, 2016
    Date of Patent: December 27, 2022
    Assignee: BODOR LABORATORIES, INC.
    Inventor: Nicholas S. Bodor
  • Publication number: 20220401410
    Abstract: Intra-oral formulations comprising soft anticholinergic alkyl esters are useful for treating excessive drooling conditions in subjects, such as humans, suffering from sialorrhea. Preferably, at least one soft anticholinergic ester is provided in an effective amount or concentration in an anhydrous intra-oral formulation that can inhibit excessive drooling resulting from a condition known as sialorrhea.
    Type: Application
    Filed: June 23, 2022
    Publication date: December 22, 2022
    Inventor: Nicholas S. BODOR
  • Patent number: 11447522
    Abstract: Potent soft corticosteroid pharmaceutical compositions comprising them and method for use as anti-inflammatory agents. Also, a method for softening fluticasone propionate and similar corticosteroids to arrive at potent but safer alternatives. The compound 5-fluoromethyl 17?-dichloroacetoxy-6?,9?-difluoro-11?-hydroxy-16a-methyl-3-oxoandrosta-1,4-diene-17?-carbothioate, which is equally potent to but safer than fluticasone, is among those provided. Another compound of particular interest is 2-hydroxyethyl 17?-dichloroacetoxy-6?,9?-difluoro-11?-hydroxy-16?-methyl-3-oxoandrosta-1,4-diene-17?-carboxylate.
    Type: Grant
    Filed: June 13, 2018
    Date of Patent: September 20, 2022
    Assignee: BODOR LABORATORIES, INC.
    Inventor: Nicholas S. Bodor
  • Publication number: 20220000839
    Abstract: Topical formulations comprising soft glycopyrrolates are useful for treating excessive sweating conditions in subjects, such as humans suffering from hyperhidrosis. Preferably, at least one soft anticholinergic agent is provided in an effective amount or concentration in an anhydrous formulation that can inhibit excessive perspiration resulting from a condition such as hyperhidrosis.
    Type: Application
    Filed: September 20, 2021
    Publication date: January 6, 2022
    Inventors: Nicholas S. BODOR, John J. KOLENG, David ANGULO
  • Patent number: 11123325
    Abstract: Topical formulations comprising soft glycopyrrolates are useful for treating excessive sweating conditions in subjects, such as humans suffering from hyperhidrosis. Preferably, at least one soft anticholinergic agent is provided in an effective amount or concentration in an anhydrous formulation that can inhibit excessive perspiration resulting from a condition such as hyperhidrosis.
    Type: Grant
    Filed: July 20, 2017
    Date of Patent: September 21, 2021
    Assignee: BODOR LABORATORIES, INC.
    Inventors: Nicholas S. Bodor, John J. Koleng, David Angulo
  • Patent number: 11084788
    Abstract: Topical formulations comprising soft glycopyrrolates are useful for treating excessive sweating conditions in subjects, such as humans suffering from hyperhidrosis. Preferably, at least one soft anticholinergic agent is provided in an effective amount or concentration in an anhydrous formulation that can inhibit excessive perspiration resulting from a condition such as hyperhidrosis.
    Type: Grant
    Filed: December 9, 2020
    Date of Patent: August 10, 2021
    Assignee: BODOR LABORATORIES, INC.
    Inventors: Nicholas S. Bodor, John J. Koleng, David Angulo
  • Publication number: 20210228544
    Abstract: Topical formulations comprising soft glycopyrrolates are useful for treating excessive sweating conditions in subjects, such as humans suffering from hyperhidrosis. Preferably, at least one soft anticholinergic agent is provided in an effective amount or concentration in an anhydrous formulation that can inhibit excessive perspiration resulting from a condition such as hyperhidrosis.
    Type: Application
    Filed: March 22, 2021
    Publication date: July 29, 2021
    Inventors: Nicholas S. BODOR, John J. KOLENG, David ANGULO
  • Patent number: 11052067
    Abstract: Topical formulations comprising soft glycopyrrolates are useful for treating excessive sweating conditions in subjects, such as humans suffering from hyperhidrosis. Preferably, at least one soft anticholinergic agent is provided in an effective amount or concentration in an anhydrous formulation that can inhibit excessive perspiration resulting from a condition such as hyperhidrosis.
    Type: Grant
    Filed: November 30, 2020
    Date of Patent: July 6, 2021
    Assignee: Bodor Laboratories, Inc.
    Inventors: Nicholas S. Bodor, John J. Koleng, David Angulo
  • Publication number: 20210198195
    Abstract: Topical formulations comprising soft glycopyrrolates are useful for treating excessive sweating conditions in subjects, such as humans suffering from hyperhidrosis. Preferably, at least one soft anticholinergic agent is provided in an effective amount or concentration in an anhydrous formulation that can inhibit excessive perspiration resulting from a condition such as hyperhidrosis.
    Type: Application
    Filed: March 15, 2021
    Publication date: July 1, 2021
    Inventors: NICHOLAS S. BODOR, JOHN J. KOLENG, DAVID ANGULO
  • Patent number: 11034652
    Abstract: Topical formulations comprising soft glycopyrrolates are useful for treating excessive sweating conditions in subjects, such as humans suffering from hyperhidrosis. Preferably, at least one soft anticholinergic agent is provided in an effective amount or concentration in an anhydrous formulation that can inhibit excessive perspiration resulting from a condition such as hyperhidrosis.
    Type: Grant
    Filed: November 16, 2020
    Date of Patent: June 15, 2021
    Assignee: BODOR LABORATORIES, INC.
    Inventors: Nicholas S. Bodor, John J. Koleng, David Angulo
  • Patent number: 11026919
    Abstract: Topical formulations comprising soft glycopyrrolates are useful for treating excessive sweating conditions in subjects, such as humans suffering from hyperhidrosis. Preferably, at least one soft anticholinergic agent is provided in an effective amount or concentration in an anhydrous formulation that can inhibit excessive perspiration resulting from a condition such as hyperhidrosis.
    Type: Grant
    Filed: November 30, 2020
    Date of Patent: June 8, 2021
    Assignee: BODOR LABORATORIES, INC.
    Inventors: Nicholas S. Bodor, John J. Koleng, David Angulo
  • Patent number: 10959983
    Abstract: Topical formulations comprising soft glycopyrrolates are useful for treating excessive sweating conditions in subjects, such as humans suffering from hyperhidrosis. Preferably, at least one soft anticholinergic agent is provided in an effective amount or concentration in an anhydrous formulation that can inhibit excessive perspiration resulting from a condition such as hyperhidrosis.
    Type: Grant
    Filed: December 5, 2019
    Date of Patent: March 30, 2021
    Assignee: BODOR LABORATORIES, INC.
    Inventors: Nicholas S. Bodor, John J. Koleng, David Angulo
  • Patent number: 10961191
    Abstract: Topical formulations comprising soft glycopyrrolates are useful for treating excessive sweating conditions in subjects, such as humans suffering from hyperhidrosis. Preferably, at least one soft anticholinergic agent is provided in an effective amount or concentration in an anhydrous formulation that can inhibit excessive perspiration resulting from a condition such as hyperhidrosis.
    Type: Grant
    Filed: November 14, 2019
    Date of Patent: March 30, 2021
    Assignee: BODOR LABORATORIES, INC.
    Inventors: Nicholas S. Bodor, John J. Koleng, David Angulo
  • Publication number: 20210087142
    Abstract: Topical formulations comprising soft glycopyrrolates are useful for treating excessive sweating conditions in subjects, such as humans suffering from hyperhidrosis. Preferably, at least one soft anticholinergic agent is provided in an effective amount or concentration in an anhydrous formulation that can inhibit excessive perspiration resulting from a condition such as hyperhidrosis.
    Type: Application
    Filed: December 9, 2020
    Publication date: March 25, 2021
    Inventors: NICHOLAS S. BODOR, JOHN J. KOLENG, DAVID ANGULO
  • Patent number: 10952990
    Abstract: Topical formulations comprising soft glycopyrrolates are useful for treating excessive sweating conditions in subjects, such as humans suffering from hyperhidrosis. Preferably, at least one soft anticholinergic agent is provided in an effective amount or concentration in an anhydrous formulation that can inhibit excessive perspiration resulting from a condition such as hyperhidrosis.
    Type: Grant
    Filed: December 5, 2019
    Date of Patent: March 23, 2021
    Assignee: BODOR LABORATORIES, INC.
    Inventors: Nicholas S. Bodor, John J. Koleng, David Angulo
  • Publication number: 20210078946
    Abstract: Topical formulations comprising soft glycopyrrolates are useful for treating excessive sweating conditions in subjects, such as humans suffering from hyperhidrosis. Preferably, at least one soft anticholinergic agent is provided in an effective amount or concentration in an anhydrous formulation that can inhibit excessive perspiration resulting from a condition such as hyperhidrosis.
    Type: Application
    Filed: November 16, 2020
    Publication date: March 18, 2021
    Inventors: NICHOLAS S. BODOR, JOHN J. KOLENG, DAVID ANGULO
  • Publication number: 20210077459
    Abstract: Topical formulations comprising soft glycopyrrolates are useful for treating excessive sweating conditions in subjects, such as humans suffering from hyperhidrosis. Preferably, at least one soft anticholinergic agent is provided in an effective amount or concentration in an anhydrous formulation that can inhibit excessive perspiration resulting from a condition such as hyperhidrosis.
    Type: Application
    Filed: November 30, 2020
    Publication date: March 18, 2021
    Inventors: Nicholas S. BODOR, John J. KOLENG, David ANGULO
  • Publication number: 20210077460
    Abstract: Topical formulations comprising soft glycopyrrolates are useful for treating excessive sweating conditions in subjects, such as humans suffering from hyperhidrosis. Preferably, at least one soft anticholinergic agent is provided in an effective amount or concentration in an anhydrous formulation that can inhibit excessive perspiration resulting from a condition such as hyperhidrosis.
    Type: Application
    Filed: November 30, 2020
    Publication date: March 18, 2021
    Inventors: Nicholas S. BODOR, John J. KOLENG, David ANGULO